- Home
- CDNA vs FBRT Comparison
CDNA vs FBRT Comparison
Compare CDNA & FBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- FBRT
- Stock Information
- Founded
- CDNA 1998
- FBRT 2012
- Country
- CDNA United States
- FBRT United States
- Employees
- CDNA N/A
- FBRT N/A
- Industry
- CDNA Medical Specialities
- FBRT Real Estate Investment Trusts
- Sector
- CDNA Health Care
- FBRT Real Estate
- Exchange
- CDNA Nasdaq
- FBRT Nasdaq
- Market Cap
- CDNA 712.2M
- FBRT 918.2M
- IPO Year
- CDNA 2014
- FBRT 1985
- Fundamental
- Price
- CDNA $14.02
- FBRT $11.44
- Analyst Decision
- CDNA Buy
- FBRT Strong Buy
- Analyst Count
- CDNA 8
- FBRT 5
- Target Price
- CDNA $26.86
- FBRT $14.90
- AVG Volume (30 Days)
- CDNA 1.4M
- FBRT 386.9K
- Earning Date
- CDNA 11-03-2025
- FBRT 11-03-2025
- Dividend Yield
- CDNA N/A
- FBRT 12.41%
- EPS Growth
- CDNA N/A
- FBRT 18.52
- EPS
- CDNA 1.00
- FBRT 0.98
- Revenue
- CDNA $340,826,000.00
- FBRT $207,768,000.00
- Revenue This Year
- CDNA $13.02
- FBRT $28.21
- Revenue Next Year
- CDNA $12.85
- FBRT $2.40
- P/E Ratio
- CDNA $13.99
- FBRT $11.67
- Revenue Growth
- CDNA 14.72
- FBRT 16.05
- 52 Week Low
- CDNA $10.96
- FBRT $9.79
- 52 Week High
- CDNA $32.97
- FBRT $13.74
- Technical
- Relative Strength Index (RSI)
- CDNA 56.93
- FBRT 55.36
- Support Level
- CDNA $13.23
- FBRT $11.58
- Resistance Level
- CDNA $13.80
- FBRT $11.68
- Average True Range (ATR)
- CDNA 0.69
- FBRT 0.17
- MACD
- CDNA 0.17
- FBRT -0.03
- Stochastic Oscillator
- CDNA 90.16
- FBRT 36.72
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.